Evidence map›Paper›PMID 26744383›Full record

ArticleBioscience reports2016

rhHMGB1 drives osteoblast migration in a TLR2/TLR4- and NF-κB-dependent manner.

Ming-Jing Li, Fan Li, Jian Xu, Yu-Dong Liu, Tao Hu, Jian-Ting Chen

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. [Expression of high-mobility group box 1 in neonates with sepsis].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2019
    Article
  15. Review
  16. Emerging role of HMGB1 in lung diseases: friend or foe.Journal of cellular and molecular medicine · 2017
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ming-Jing LiDepartment of Orthopedic and Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China Department of Pediatric Orthopedic, Wuhan PuAi Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan 430030, China.
Fan LiDepartment of Pediatric Orthopedic, Wuhan PuAi Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan 430030, China.
Jian XuDepartment of Pediatric Orthopedic, Wuhan PuAi Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan 430030, China.
Yu-Dong LiuDepartment of Pediatric Orthopedic, Wuhan PuAi Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan 430030, China.
Tao HuDepartment of Pediatric Orthopedic, Wuhan PuAi Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan 430030, China.
Jian-Ting ChenDepartment of Orthopedic and Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China chenjt2015@tom.com.
Huazhong University of Science and Technology · CNNanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoblast migration is significant in skeletal development. Recently, high mobility group box 1 protein (HMGB1) has been shown to highly expressed in cartilage to regulate endochondral ossification. Nevertheless, whether HMGB1 can modulate osteoblast proliferation and migration is poorly understood, as well as the intracellular signalling pathways that are involved in this process. Herein, we examined the effects of recombinant human HMGB1 (rhHMGB1) on the proliferation and migration of rat osteoblasts and investigated whether Toll-like receptor 2 (TLR2)- and TLR4-dependent signalling pathways are involved in the regulation of intracellular signalling. A transwell chamber assay was used to evaluate the migration of osteoblasts and the MTT assay was used to assess osteoblast proliferation. rhHMGB1 could significantly promote the migration of osteoblasts without inhibiting their proliferation. Meanwhile, rhHMGB1 can increase the nuclear translocation of nuclear factor-kappa B (NF-κB) p65. Specific siRNA constructs that target TLR2 or TLR4 could markedly inhibit HMGB1-induced migration of osteoblasts and HMGB1-enhanced activation of NF-κB. Collectively, HMGB1 could significantly enhance the migration of osteoblasts in vitro, and TLR2/TLR4-dependent NF-κB pathways are involved in HMGB1-induced osteoblast migration.

Indexed as

AnimalsCell MovementHMGB1 ProteinHumansOsteoblastsRatsRats, Sprague-DawleySignal TransductionToll-Like Receptor 2Toll-Like Receptor 4Transcription Factor RelAHMGB1 ProteinHMGB1 protein, humanRela protein, ratTlr2 protein, ratTlr4 protein, ratToll-Like Receptor 2Toll-Like Receptor 4Transcription Factor RelAmigrationosteoblastproliferationrecombinant human high mobility group box 1 protein (rhHMGB1)siRNAskeletal development

Identifiers

PMID26744383
PMCPMC4759610
OpenAlexW2334523018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.